Invention Grant
- Patent Title: Diagnostic drug and diagnostic method for Alzheimer's disease
-
Application No.: US17265805Application Date: 2019-08-06
-
Publication No.: US12000844B2Publication Date: 2024-06-04
- Inventor: Atsushi Ono , Yasuhiro Teranishi , Masanori Kusumoto , Masakazu Hashimoto , Shoji Kashiwabara , Maki Hashimoto
- Applicant: SUMITOMO PHARMA CO., LTD.
- Applicant Address: JP Osaka
- Assignee: SUMITOMO PHARMA CO., LTD.
- Current Assignee: SUMITOMO PHARMA CO., LTD.
- Current Assignee Address: JP Osaka
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: JP 18148924 2018.08.07
- International Application: PCT/JP2019/030904 2019.08.06
- International Announcement: WO2020/032027A 2020.02.13
- Date entered country: 2021-02-03
- Main IPC: C07K16/18
- IPC: C07K16/18 ; G01N33/15 ; G01N33/531 ; G01N33/68
Abstract:
The present invention provides a polypeptide consisting of any of the following amino acid sequences and useful for determining Alzheimer's disease:
(1) the amino acid sequence shown in SEQ ID NO: 1; and
(2) an amino acid sequence resulting from substitution, deletion, addition or insertion of one to several amino acids in the amino acid sequence shown in SEQ ID NO: 1.
(1) the amino acid sequence shown in SEQ ID NO: 1; and
(2) an amino acid sequence resulting from substitution, deletion, addition or insertion of one to several amino acids in the amino acid sequence shown in SEQ ID NO: 1.
Public/Granted literature
- US20210165002A1 DIAGNOSTIC DRUG AND DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE Public/Granted day:2021-06-03
Information query
